Financial PerformanceThe company has €438.3 million in cash and equivalents, expected to fund operations into 2028, providing a strong financial foundation.
Intellectual PropertyThe European Patent Office confirmed the validity of CVAC patent EP 4 023 755 B1, which is a foundational technology for the company.
Legal DevelopmentsA positive infringement ruling could trigger damage assessment proceedings, potentially leading to significant revenue for the company.